Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy

Osimertinib has demonstrated efficacy against stable or asymptomatic central nervous system (CNS) metastases of epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC) in phase 2 and 3 clinical trials that allowed prior CNS radiotherapy. However, the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameku, Koken, Higa, Mariko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109584/
https://www.ncbi.nlm.nih.gov/pubmed/32257480
http://dx.doi.org/10.1155/2020/9076168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109584/
https://www.ncbi.nlm.nih.gov/pubmed/32257480
http://dx.doi.org/10.1155/2020/9076168

Ejemplares similares